Life Sciences

How Are Regulatory Reforms Unlocking Clinical Trials in Brazil?
Public Policy How Are Regulatory Reforms Unlocking Clinical Trials in Brazil?

The proportion of clinical trials receiving approval within only one or two review rounds surged to 81% in 2026, marking a major efficiency milestone. This dramatic shift highlights the success of recent legislative efforts aimed at dismantling the bureaucratic hurdles that once defined the

How Will the New PhD Hub Reshape South African Biotech?
Workforce How Will the New PhD Hub Reshape South African Biotech?

The collaboration between Rhodes University and the Council for Scientific and Industrial Research aims to ensure that biotechnology innovations reach local communities. This strategic partnership marks a departure from traditional academic silos, positioning South Africa as a burgeoning leader in

Can Jihui Hao Bridge the Global Gap in Cancer Care?
Organizational Governance Can Jihui Hao Bridge the Global Gap in Cancer Care?

One primary objective of Jihui Hao’s candidacy is to align China’s internal oncological policies with the global best practices advocated by the Union for International Cancer Control. As a central figure in the modern medical landscape, Professor Hao’s bid for the 2026–2028 term reflects a strateg

Can AI Replace Subjective Grades for Cervical Disc Decay?
Technology Can AI Replace Subjective Grades for Cervical Disc Decay?

While high-resolution MRI hardware provides clear images, the lack of a standardized numerical scale makes longitudinal monitoring of spinal health nearly impossible. For the millions of individuals currently managing chronic neck pain, the diagnostic journey frequently leads to a Magnetic

IBEC Joins EU Initiative to Advance Quantum Cancer Imaging
Data and Information IBEC Joins EU Initiative to Advance Quantum Cancer Imaging

Moving quantum-enhanced imaging into the clinical mainstream involves establishing a standardized infrastructure for metabolic monitoring across seven different nations. The Institute for Bioengineering of Catalonia, situated in Barcelona, has formally aligned with the Q-AID project, an ambitious

Will AstraZeneca’s $2 Billion Deal Transform Cancer Therapy?
Business Will AstraZeneca’s $2 Billion Deal Transform Cancer Therapy?

Faisal Zain is a distinguished leader in the biopharmaceutical sector, renowned for his strategic oversight in oncology drug development and the manufacturing of complex therapeutic platforms. With a career dedicated to bridging the gap between innovative clinical research and commercial viability,

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later